v3.24.1.u1
Cover - shares
3 Months Ended
Mar. 31, 2024
Apr. 30, 2024
Cover [Abstract]    
Document Type 10-Q  
Document Quarterly Report true  
Document Period End Date Mar. 31, 2024  
Document Transition Report false  
Entity File Number 001-36297  
Entity Registrant Name Revance Therapeutics, Inc.  
Entity Incorporation, State or Country Code DE  
Entity Tax Identification Number 77-0551645  
Entity Address, Address Line One 1222 Demonbreun Street, Suite 2000  
Entity Address, City or Town Nashville  
Entity Address, State or Province TN  
Entity Address, Postal Zip Code 37203  
City Area Code 615  
Local Phone Number 724-7755  
Title of 12(b) Security Common Stock, par value $0.001 per share  
Trading Symbol RVNC  
Security Exchange Name NASDAQ  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Large Accelerated Filer  
Entity Emerging Growth Company false  
Entity Small Business false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   104,448,502
Entity Central Index Key 0001479290  
Current Fiscal Year End Date --12-31  
Document Fiscal Year Focus 2024  
Document Fiscal Period Focus Q1  
Amendment Flag false